In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.
| Author: Christopher P. Cannon |
| Publisher: Humana |
| Publication Date: Nov 04, 2002 |
| Number of Pages: 783 pages |
| Binding: Hardback or Cased Book |
| ISBN-10: 1588291308 |
| ISBN-13: 9781588291301 |
Related Products
Sale 11%
